Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Income Before (Loss) Income Tax, Domestic and Foreign

The following table presents domestic and foreign components of loss before income taxes as follows for the periods indicated:

	Year Ended December 31,
(in thousands)	2025		2024		2023
Domestic	$	(12,462)	$	(28,332)	$	(104,161)
Foreign	6,524		(1,218)		2,272
Loss before taxes	$	(5,938)	$	(29,550)	$	(101,889)

Schedule of Components of Income Tax Expense (Benefit)

The federal, state and foreign components of the income tax expense (benefit) are summarized as follows for the periods indicated:

	Year Ended December 31,
(in thousands)	2025		2024		2023
Current:
Federal	$	146	$	9	$	34
State	224		133		216
Foreign	1,332		3,001		3,793
Total current income tax expense	1,702		3,143		4,043
Deferred:
Federal	—		—		(4,137)
State	—		—		(633)
Foreign	1,879		(3,595)		(1,046)
Total deferred tax expense (benefit)	1,879		(3,595)		(5,816)
Total income tax expense (benefit)	$	3,581	$	(452)	$	(1,773)

Schedule of Effective Income Tax Rate Reconciliation

The Company adopted ASU 2023-09 on a prospective basis beginning December 31, 2025. The following table presents the required disclosure pursuant to ASU 2023-09 and is a reconciliation of the Company's income tax expense at the statutory federal tax rate to the Company's effective tax rate for the year ended December 31, 2025:

	Year Ended December 31,
(in thousands)	2025
U.S. federal statutory income tax rate	$	(1,247)	21.0	%
State and local taxes, net of federal benefit (1)	227		(3.8)
Foreign tax effects
China
Statutory tax rate difference between China and U.S.	(217)		3.7
Changes in valuation allowance	2,745		(46.2)
Other	(916)		15.4
United Kingdom
Statutory tax rate difference between United Kingdom and U.S.	189		(3.2)
Other	388		(6.5)
Other foreign jurisdictions	111		(1.9)
Tax credits - research and development	(108)		1.8
Change in valuation allowance	(1,871)		31.5
Nontaxable or nondeductible items
Officer compensation	700		(11.8)
Share-based compensation	1,870		(31.5)
Change in fair value of warrants	(102)		1.7
Other	729		(12.3)
Changes in worldwide unrecognized tax benefits	208		(3.5)
Other provision adjustments	875		(14.7)
Income tax expense	$	3,581	(60.3)	%

(1) State taxes in Texas comprise the majority (greater than 50%) of the tax effect in this category.

The following table presents the required disclosures prior to the adoption of ASU 2023-09 and is a reconciliation of the Company's income tax benefit at the statutory federal tax rate to the Company's effective tax rate for the years ended December 31, 2024 and 2023:

	Year Ended December 31,
(in thousands)	2024				2023
Federal statutory income tax rate	$	(6,206)	21.0	%	$	(21,398)	21.0	%
State taxes, net of federal benefit	475		(1.6)		(3,083)		3.0
Officer compensation	905		(3.1)		844		(0.8)
Change in fair value of warrants	(644)		2.2		(2,503)		2.5
Share-based compensation	5,130		(17.4)		2,922		(2.9)
Foreign rate differential	(64)		0.2		338		(0.3)
R&D credit	(289)		1.0		(824)		0.8
Permanent differences	296		(1.0)		2,183		(2.1)
Change in valuation allowance	1,006		(3.4)		18,400		(18.1)
Other	(1,061)		3.6		1,348		(1.3)
Income tax benefit	$	(452)	1.5	%	$	(1,773)	1.7	%

Schedule of Cash Paid for Income Taxes, Net of Refunds Received

The following table presents cash paid for income taxes, net of refunds received, by jurisdiction during the year ended December 31, 2025:

(in thousands)
Federal
Aggregated state and local jurisdictions (2)	$	84
Foreign
United Kingdom	3,218
Germany	275
Australia	249
China	245
All other foreign (2)	(121)
Total cash paid for income taxes, net of refunds	$	3,950

(2) The amount of income taxes paid during the year ended December 31, 2025 does not meet the 5% disaggregation threshold.

Schedule of Deferred Tax Assets and Liabilities

The components of the deferred tax assets are as follows for the periods indicated:

(in thousands)	December 31, 2025		December 31, 2024
Deferred income tax assets
State taxes	$	28	$	20
Accrued expenses	4,029		3,497
Inventories	4,848		6,226
Accounts receivable	821		1,840
Section 163(j) limitation	7,427		6,822
Net operating loss carryforwards	15,499		11,722
Share-based compensation	2,421		2,927
Lease liabilities	3,572		3,983
Capitalized research	2,592		5,249
Property and equipment	1,119		—
Other	2,580		3,480
Total deferred income tax assets	44,936		45,766
Deferred income tax liabilities
Goodwill and intangibles	(2,260)		(3,710)
Prepaid expenses	—		(283)
Convertible debt premium	(3,415)		—
Right-of-use assets	(2,889)		(3,401)
Property and equipment	—		(630)
Total deferred tax liabilities	(8,564)		(8,024)
Valuation allowance	(34,840)		(34,244)
Net deferred income tax assets	$	1,532	$	3,498

The Company’s net deferred income tax assets as presented on the Consolidated Balance Sheets consists of the following items as of the dates indicated:

(in thousands)	December 31, 2025		December 31, 2024
Deferred income tax assets	$	1,925	$	3,894
Deferred income tax liabilities	(393)		(396)
Net deferred income tax assets	$	1,532	$	3,498

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending balances of unrecognized tax benefits is as follows:

(in thousands)	December 31, 2025		December 31, 2024
Unrecognized tax benefits at beginning of period	$	1,194	$	1,104
Increases for tax positions in prior periods	422		—
Decreases for tax positions in prior periods	—		(54)
Increases for tax positions in current period	121		261
Settlements/statute expirations	—		(117)
Unrecognized tax benefits at end of period	$	1,737	$	1,194